Clinical Pharmacokinetics of Depot Leuprorelin

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.7, 2002-01, pp. : 485-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depot medroxyprogesterone vs leuprorelin in endometriosis

Inpharma, Vol. 1, Iss. 1532, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Leuprorelin depot not inferior to chemo for nodal breast cancer

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

The anti-inflammatory action of danazol and leuprorelin acetate depot on endometriosis is CRH independent

By Matalliotakis Ioannis M.

Inflammopharmacology, Vol. 9, Iss. 3, 2001-06 ,pp. : 249-255

VSP

Access to resources Recommend Favorite

Pharmacokinetics of intramuscular microparticle depot of valdecoxib in an experimental model

By Agnihotri Sagar M. Vavia Pradeep R.

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 9, 2009-09 ,pp. : 1043-1047

Informa Healthcare

Access to resources Recommend Favorite

Leuprorelin: Granulomas in an elderly patient following SC administration of depot injections containing polymers: case report

Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite